Literature DB >> 24278064

Illness acceptance degree versus intensity of psychopathological symptoms in patients with psoriasis.

Magdalena Kostyła1, Klaudia Tabała, Józef Kocur.   

Abstract

INTRODUCTION: Chronic inflammatory skin diseases such as psoriasis have undoubtedly a negative impact on the patients' quality of life. Many of them may face various limitations in their psychosocial lives because of symptoms indicating the presence of psychopathological phenomena. Mental disorders in patients with skin diseases occur much more frequently than in the general population. Studies show that a considerable percentage (30-60%) of dermatological patients suffers from mental disorders (depressive and anxiety disorders being the most common). A person's attitude towards illness, its acceptance, and also the recognition of its limitations may be of a great importance in the process of the disease control. AIM: To evaluate of the relationship between the illness acceptance degree, and the presence and intensity of psychopathological symptoms in patients with psoriasis.
MATERIAL AND METHODS: The research was conducted on a group of 54 people (23 men and 31 women), who were treated for psoriasis in the Department of Dermatology and Venereology, Medical University of Lodz and in the Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz. The following research methods were used: a questionnaire prepared for the purpose of the research, Acceptance of Illness Scale (AIS) and Symptom Checklist (SCL-90).
RESULTS: It was found that there was a relationship between the skin illness acceptance degree and intensity of psychopathological symptoms in patients with psoriasis (negative correlations).
CONCLUSIONS: The higher the degree of illness acceptance is, the better mental condition of patients with psoriasis is. The intensity of psychopathological symptoms is also affected by the duration of illness, other people's attitude to the skin disease, age and education level of the patients examined.

Entities:  

Keywords:  illness acceptance; psoriasis; psychopathology

Year:  2013        PMID: 24278064      PMCID: PMC3834715          DOI: 10.5114/pdia.2013.35613

Source DB:  PubMed          Journal:  Postepy Dermatol Alergol        ISSN: 1642-395X            Impact factor:   1.837


Introduction

Children and adults suffering from skin diseases are more likely to develop mental disorders than people in the general population [1]. Stress, feeling of social stigmatization, limitations in various aspects of life, and also pain and itching, result in the development of various mental disorders in some patients [2, 3]. Among patients with skin diseases, 30% of people receiving ambulatory treatment and 60% of hospitalized patients [1, 4] showed psychopathological symptoms. Research of Aktan et al. [5], Linnet and Jemec [6] revealed that depression and an increased level of anxiety were most common mental disorders. Similar results were obtained by other researchers [7-9]. Apart from mood and anxiety disorders, some authors pointed out to other mental dysfunctions in dermatological patients such as: hypochondriac delusions, somatoform disorder, obsessive-compulsive disorder, posttraumatic stress disorder (PTSD), schizotypal disorder, body dysmorphic disorder and personality disorders [10, 11]. The research of Parafianowicz et al. [12] revealed that mental disorders were four times more frequent in patients with psoriasis than in patients suffering from other skin diseases. In the process of adaptation to the life with a chronic disease it is important to learn to gradually accept it. Indications suggest that an increased acceptance of the illness-related limitations results in better adaptation, lower mental discomfort, lower stress level and higher self-esteem [13]. Focusing on the emotional state and psychological condition of patients with dermatological illnesses enables researchers to see and better understand their needs. This may consequently provide more therapeutic treatment opportunities by using specific methods of psychological support.

Aim

The main objective of this study is to assess whether there is a relationship between the degree of illness acceptance and the presence and intensity of psychopathological symptoms in patients with psoriasis. Furthermore, the impact of the following variables has been analyzed: illness duration, tendency to hide pathological dermal changes, subjective assessment of the skin disease impact on the patient's worse mood, experiencing a different (stigmatizing) treatment due to the skin disease and its impact on the presence and intensity of psychopathological symptoms.

Material and methods

The research was conducted on a group of 54 people receiving treatment for psoriasis in the Department of Dermatology and Venereology, Medical University of Lodz and in the Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz (23 men and 31 women) at the age of 18 to 77 years (M = 49.18; SD = 15.32). The patients’ attitude to difficulties and limitations caused by psoriasis was analyzed with the help of the Acceptance of Illness Scale AIS (developed by B.J. Felton, T.A. Revenson and G.A. Hinrichsen, Polish adaptation by Z. Juczyński [14]), while the presence and intensity of psychopathological symptoms were assessed with the use of the Symptom Checklist SCL-90 (L.R. Derogatis, R.S. Lipman and L. Covi [15]), which covers nine general symptoms – 9 scales: somatization, obsessive-compulsive disorder, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism. Table 1 shows how symptoms speaking for psychopathologies are understood in particular scales.
Table 1

Description of subscales in the Scale of Clinical Psychopathological Symptoms SCL-90 [15]

ScaleWhat does the scale measure?
SomatizationDiscomfort caused by somatic ailments characteristic of neurosis (questions about e.g. symptoms involving the myocardium, respiratory system, stomach, myalgia)
Obsessive-compulsive disorderPresence of obsessive-compulsive thoughts and compulsive activities; this scale also comprises more general cognitive impairments (e.g. mind going blank, recollection of problems)
Interpersonal sensitivityFeeling of interpersonal inadequateness, inferiority, tendency towards self-deprecation, discomfort in social situations (hypersensitivity, negative expectations about interpersonal communication)
DepressionBad mood, dysphoria, anhedonia, loss of interest, loss of energy and motivation, feeling of helplessness and hopelessness, suicidal thoughts; this scale also comprises cognitive and somatic symptoms of depression
AnxietyAnxiety, irritability, tension, also somatic symptoms of anxiety, such as palpitation, excitement, questions about acute and general anxiety
HostilityIrritability, annoyance, predisposition to impulsive destruction of objects and frequent uncontrollable outbursts of anger
Phobic anxietyEpisodes of acute anxiety states and agoraphobia (fear of travelling, open spaces, crowds, public places)
Paranoid ideationSuspicion, hostility, mistrust towards others, projective thinking
PsychoticismAuditory hallucinations, transmission and insertion of thoughts, controlling thoughts from the outside and indicators of the schizoid lifestyle
Description of subscales in the Scale of Clinical Psychopathological Symptoms SCL-90 [15] A questionnaire was also specially designed for the test needs. It allowed us to gather sociodemographic data (sex, age, education, residence, marital status) and obtain more detailed data about skin diseases (e.g. their duration, a tendency to hide pathological dermal changes, a subjective assessment of the illness impact on the patient's worse mood, experiencing a different treatment from others because of the skin disease).

Statistical analysis

Statistical analysis was made using the Statistica 8 package. The Pearson product-moment correlation coefficient was used to assess the relationship between particular variables. The groups were compared using the Student's t-test, Mann-Whitney U-test or the Kruskal-Wallis test depending on the type of data and number of groups. In the analysis performed, the significance level of p < 0.05 was statistically significant.

Results

The research shows the existence of a relationship between the degree of skin disease acceptance and intensity of some psychopathological symptoms in patients with psoriasis (negative correlations) (Table 2).
Table 2

Correlation between the degree of psoriasis acceptance (AIS scale) and intensity of psychopathological symptoms

AISSOMNATRINTDEPLĘKWROGFOBMPARPSYCHOT
Pearson correlation−0.362−0.349−0.418−0.226−0.325−0.221−0.134−0.232−0.403
Significance (bilateral)0.0070.0100.0020.1000.0170.1090.3360.0910.002
N 545454545454545454

AIS – the degree of illness acceptance, SOM – somatization, NATR – obsessive-compulsive disorder, INT – interpersonal sensitivity, DEP – depression,LĘK – anxiety, WROG – hostility, FOB – phobic anxiety, MPAR – paranoid ideation, PSYCHOT – psychoticism

Correlation between the degree of psoriasis acceptance (AIS scale) and intensity of psychopathological symptoms AIS – the degree of illness acceptance, SOM – somatization, NATR – obsessive-compulsive disorder, INT – interpersonal sensitivity, DEP – depression,LĘK – anxiety, WROG – hostility, FOB – phobic anxiety, MPAR – paranoid ideation, PSYCHOT – psychoticism While the level of illness (psoriasis) acceptance grows, the intensity of psychopathological symptoms such as somatization, obsessive-compulsive disorder, interpersonal sensitivity, anxiety or psychoticism gets lower. The patients’ mental state was also analyzed in terms of how much the duration of illness affects it. At a statistically significant level there is a relationship between the duration of psoriasis and the intensity of interpersonal sensitivity (r = 0.36 at p < 0.05) – the longer the patient suffers from psoriasis, the stronger his/her discomfort is in interpersonal contacts (a sense of inferiority, interpersonal inadequateness). The average duration period of the skin disease in the examined group of patients has been 16 years. In the research, also an impact of intensity of psychopathological symptoms such as a tendency to hide pathological dermal changes and the environment response to the illness has been considered (Figure 1):
Fig. 1

Tendency to hide pathological dermal changes and assessment of environment's response to the illness

42 people (78%) confirmed that they intentionally hide their illness, e.g. under their clothes and make-up; 12 people (22%) denied doing it; half of people tested (27 people) confirmed that they have experienced bad treatment from other people because of their skin disease (aversion, avoiding contact); the other half denied being treated badly by other people. Tendency to hide pathological dermal changes and assessment of environment's response to the illness It turned out that the way a sick person is treated by others has an impact on the intensity of psychopathological symptoms. However, we failed to confirm the hypothesis that there is a relationship between the tendency to hide skin changes and the intensity of psychopathological symptoms in patients with psoriasis (Table 3).
Table 3

Intensity of psychopathological symptoms versus other people's attitude

StigmatizationLack of stigmatizationValue of t Value of p
SOM M 17.5913.482.310.02
SD 5.977.07
NATR M 14.0710.702.120.04
SD 6.195.45
INT M 14.748.363.94< 0.01
SD 5.835.55
MPAR M 8.676.882.330.02
SD 2.772.79
PSYCHOT M 8.935.413.23< 0.01
SD 4.043.97

SOM – somatization, NATR – obsessive-compulsive disorder, INT – interpersonal sensitivity, MPAR – paranoid ideation, PSYCHOT – psychoticism

Intensity of psychopathological symptoms versus other people's attitude SOM – somatization, NATR – obsessive-compulsive disorder, INT – interpersonal sensitivity, MPAR – paranoid ideation, PSYCHOT – psychoticism Average results obtained in the following scales: somatization, obsessive-compulsive disorder, interpersonal sensitivity, paranoid ideation and psychoticism are significantly higher in a group of people who have experienced different (stigmatizing) treatment because of the skin disease (aversion, avoiding contact) than among people who did not experience such behaviour. In the questionnaire, participants described a degree to which psoriasis affected their worse mood (impact: big, average, small, none – no one ticked the answer: no impact). In the research it was checked whether there is a relationship between the intensity of psychopathological symptoms and subjective assessment of the illness impact on the patients’ worse mood (Table 4).
Table 4

Intensity of psychopathological symptoms and subjective assessment of the psoriasis impact on worse mood

Big impact (n = 18)Average impact (n = 31)Small impact (n = 5) H Value of p Mann-Whitney U-test
MSDMSDMSD1-22-31-3
SOM 18.835.6514.586.649.606.847.680.021NSNS0.015
NATR 15.895.9310.975.318.605.599.400.0090.006NSNS
INT 15.725.3210.106.167.004.7412.460.0020.002NS0.009
DEP 21.677.6812.976.5811.807.9213.520.001< 0.001NS0.009
LĘK 14.394.8110.295.806.204.979.080.011NSNS0.007
PSYCHOT 9.674.596.423.542.803.2711.870.0030.012NS0.008

SOM – somatization, NATR – obsessive-compulsive disorder, INT – interpersonal sensitivity, DEP – depression, LĘK – anxiety, PSYCHOT – psychoticism, NS – not significant

Intensity of psychopathological symptoms and subjective assessment of the psoriasis impact on worse mood SOM – somatization, NATR – obsessive-compulsive disorder, INT – interpersonal sensitivity, DEP – depression, LĘK – anxiety, PSYCHOT – psychoticism, NS – not significant Average results in the somatization, obsessive-compulsive disorder, interpersonal sensitivity, depression, anxiety and psychoticism scales are different in groups assessing the psoriasis impact on their worse mood differently (statistically significant differences between subgroups 1-2 and 1-3). The highest results were obtained in the group describing the psoriasis impact as big. In terms of sociodemographic changes, a statistically significant relationship between the age and intensity of symptoms measured with hostility scale (r = –0.27) and obsessive-compulsive disorder scale (r = 0.29) was observed. The intensity of “obsessive-compulsive disorder” in patients with psoriasis grows with age. However, the level of “hostility” in this group of people decreases with age. The intensity of some psychopathological symptoms depends on the level of education (Table 5).
Table 5

Intensity of psychopathological symptoms and the level of education

Vocational education (n = 9)Secondary education (n = 31)Higher education (n = 13) H Value of p Mann-Whitney U-test
MSDMSDMSD1-22-31-3
DEP 195.5714.948.0912.316.8510.330.0060.008NS0.001
WROG 7.892.427.263.594.462.737.840.020NSNS0.007
MPARA 10.672.837.682.536.463.418.660.0130.008NS0.014

DEP – depression, WROG – hostility, MPARA – paranoid ideation, NS – not significant

Intensity of psychopathological symptoms and the level of education DEP – depression, WROG – hostility, MPARA – paranoid ideation, NS – not significant Average results in the depression, hostility and paranoid ideation scales in patients with psoriasis differ depending on the level of education (statistically significant differences between subgroups 1-2 and 1-3). The highest results were obtained in the group of people with vocational education and the lowest in the group of people with higher education. The variable of “primary education” was excluded from the analysis because of a low number of its representatives. At a statistically significant level no relationship between sex, place of residence, marital status and the intensity of psychopathological symptoms in patients with psoriasis was found.

Discussion

Before undertaking the research with the participation of psoriasis patients, it was assumed that the degree of illness acceptance depends on the patients’ mental condition. The results confirm this assumption (with reference to the somatization, obsessive-compulsive disorder, interpersonal sensitivity, anxiety and psychoticism scales at a statistically significant level) and indicate that if the patient has adapted to the illness and its limitations, his/her mental condition is much better. The lowest results in the psychopathological symptoms scale were obtained by people who believe that psoriasis has a small effect on their general condition (in comparison to those who regarded the impact as big or moderate). No psoriasis acceptance and the conviction that the illness has a negative impact on people's performance and general condition may thus lead to various somatic complaints (perhaps of neurotic background), the increase in tension, anxiety, depression, appearance of tiring, obsessive thoughts, regarding oneself as someone inferior, unattractive in contacts, less valuable and even to complete isolation from the society, distancing from one's emotions, loss of the ability to feel pleasure (which indicates a pathological lifestyle). To some extent, these results correspond with the report presented by King et al. [16] who indicate that patients regarding their illness as a challenge worth their efforts have better chances of adaptation. Otherwise, negative emotional states may occur (feeling of helplessness, lowered self-esteem, depression, disturbed sense of identity) causing disturbance in one's thinking and disorganizing their performance. Barton et al. and Shortus et al. [17, 18] pointed out that the degree of illness advancement and its duration also has an impact on the degree of illness acceptance. In our research we obtained a result indicating that the longer the skin illness lasted, the sensitivity in interpersonal relations got higher (discomfort, anxiety, feeling of inferiority, anticipation of rejection). Indications suggest [19, 20] that people with psoriasis regard their bodies as “impure”, having a “flaw”, which further results in feelings of guilt and shame, causes greater sensitivity to other people's opinions and anticipation of rejection. Hawro et al. [21] presented their results indicating that the feeling of rejection in patients with psoriasis, seen as e.g. avoiding social situations, grew with age, and that the longer the duration of illness, the stronger the anticipation of rejection. Furthermore, it turns out that the improvement in the patients’ somatic state has not changed their opinion on social rejection and the feeling of stigmatization – therefore, the authors of the research suggest a necessity to plan interdisciplinary actions (a combination of pharmacotherapy and psychotherapeutic support), which are recommended – where reasonable – by the authors of this study. The way a person is seen and judged by others is an important element of their psychosocial behaviour. According to Hrehorów et al. [22], both in Poland and in other countries the problem of stigmatization of people with psoriasis has been seldom addressed by researchers. People suffering from skin diseases often encounter fear and prejudice from others, which may come from a false belief that “psoriasis is contagious” [23]. Our research shows that half of the patients have experienced different treatment because of their skin disease. The intensity of psychopathological symptoms (measured with the somatization, obsessive-compulsive disorder, interpersonal sensitivity, paranoid ideation and psychoticism scales) is significantly higher compared to the group of people who do not experience such behaviour. Ginsburg and Link [24, 25] indicated the presence of the following feelings and beliefs in people suffering from psoriasis: a feeling of being “defective”, guilty and ashamed, sensitivity to other people's opinions, anticipation of rejection from the society, a belief that their illness should be a secret, experiencing pity and compassion from others. In our own research also the analysis of the impact of sociodemographic variables on the intensity of psychopathological symptoms in patients with psoriasis was presented. Statistically significant data referred only to the level of education and age. It turns out that people with a higher education obtained lower results in the SCL-90 scale than people with secondary or vocational education. This result may be interpreted in reference to the research by Chodorowska et al. [26] on the patients’ level of interest in their disease. Patients with a higher education more often turned to professional literature, Internet or requested pharmaceutical advice. The research of Kowalczuk et al. [27] also proved that patients with a higher education had greater knowledge on psoriasis. Furthermore, this research showed that the level of knowledge corresponded to the patients’ quality of life. In numerous studies on patients with psoriasis, the impact of age on various aspects of the life with this chronic disease has been often analyzed – their results are not conclusive. Our research has confirmed the relationship between the age and intensity of obsessive thoughts (positive correlation) and hostility (negative correlation). The first result seems compatible with the reports of Miniszewska [20] who indicates that older people (over 40 years of age) complained more about their disease as they were worried about the severity of their illness, afraid that their condition could become worse, had sleeping problems. They lived in isolation, limited their social contacts and stayed at home – this could explain the results regarding hostility (inability to experience this feeling due to a small number of interpersonal contacts). Different results were obtained by Janowski [28], who indicated that older people regarded their disease as a value helping them develop internally.

Conclusions

Results of the research conducted show a negative impact of psoriasis on psychosocial lives of people and the presence of psychopathological symptoms in this group of patients. The degree of the illness acceptance is greater in psoriasis patients in a better mental condition. No illness acceptance results in the increase in tension, anxiety, depression, presence of tiring, obsessive thoughts, feeling of inferiority, unattractiveness in contacts with others, isolation, distancing from one's emotions, loss of the ability to feel pleasure. The research shows that the following variables also have an impact on the intensity of psychopathological symptoms in psoriasis patients: illness duration, subjective assessment of the psoriasis impact on the patient's worse mood, attitude of other people, age and level of education.
  16 in total

1.  Turning points and protective processes in the lives of people with chronic disabilities.

Authors:  Gillian King; Tamzin Cathers; Elizabeth Brown; Jacqueline A Specht; Colleen Willoughby; Janice Miller Polgar; Elizabeth MacKinnon; Linda K Smith; Lisa Havens
Journal:  Qual Health Res       Date:  2003-02

2.  SCL-90: an outpatient psychiatric rating scale--preliminary report.

Authors:  L R Derogatis; R S Lipman; L Covi
Journal:  Psychopharmacol Bull       Date:  1973-01

3.  Sex differences in the psychological effects of psoriasis.

Authors:  R K Roenigk; H H Roenigk
Journal:  Cutis       Date:  1978-04

4.  Patients' views on chronic illness and its care in general practice.

Authors:  Tim Shortus; Vanessa Rose; Elizabeth Comino; Nicholas Zwar
Journal:  Aust Fam Physician       Date:  2005-05

5.  An assessment of anxiety and dermatology life quality in patients with atopic dermatitis.

Authors:  J Linnet; G B Jemec
Journal:  Br J Dermatol       Date:  1999-02       Impact factor: 9.302

6.  Psychosocial consequences of rejection and stigma feelings in psoriasis patients.

Authors:  I H Ginsburg; B G Link
Journal:  Int J Dermatol       Date:  1993-08       Impact factor: 2.736

Review 7.  Coping as a mediator of psychosocial impediments to optimal management and control of asthma.

Authors:  Christopher Barton; David Clarke; Nabil Sulaiman; Michael Abramson
Journal:  Respir Med       Date:  2003-07       Impact factor: 3.415

8.  [The level of approval in selected chronic diseases].

Authors:  Antoni Niedzielski; Ewa Humeniuk; Przemysław Błaziak; Dorota Fedoruk
Journal:  Wiad Lek       Date:  2007

Review 9.  [The role of psychological factors and psychiatric disorders in skin diseases].

Authors:  Marta Kieć-Swierczyńska; Bohdan Dudek; Beata Krecisz; Dominika Swierczyńska-Machura; Wojciech Dudek; Adrianna Garnczarek; Katarzyna Turczyn
Journal:  Med Pr       Date:  2006       Impact factor: 0.760

10.  Trivial or terrible? The psychosocial impact of psoriasis.

Authors:  R G Fried; S Friedman; C Paradis; M Hatch; Y Lynfield; C Duncanson; A Shalita
Journal:  Int J Dermatol       Date:  1995-02       Impact factor: 2.736

View more
  11 in total

1.  Illness Acceptance as the Measure of the Quality of Life in Moderate Psoriasis.

Authors:  Barbara Jankowiak; Beata Kowalewska; Elżbieta Krajewska-Kułak; Rafał Milewski; Maria Anna Turosz
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-08-28

2.  Psychopathology and alexithymia in patients with psoriasis.

Authors:  Panagiota Korkoliakou; Vasiliki Efstathiou; Ioanna Giannopoulou; Christos Christodoulou; Anargyros Kouris; Dimitrios Rigopoulos; Athanasios Douzenis
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

3.  Itch, disease coping strategies and quality of life in psoriasis patients.

Authors:  Alicja Ograczyk; Joanna Miniszewska; Anna Kępska; Anna Zalewska-Janowska
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

4.  Quality of life and severity of skin changes in the dynamics of psoriasis.

Authors:  Krzysztof Owczarek; Mariusz Jaworski
Journal:  Postepy Dermatol Alergol       Date:  2016-05-16       Impact factor: 1.837

5.  Generalized Self-Efficacy, Dispositional Optimism, and Illness Acceptance in Women with Polycystic Ovary Syndrome.

Authors:  Ewa Rzońca; Grażyna Iwanowicz-Palus; Agnieszka Bień; Artur Wdowiak; Ryszard Szymański; Gustaw Chołubek
Journal:  Int J Environ Res Public Health       Date:  2018-11-07       Impact factor: 3.390

6.  Effect of Disease Severity on the Quality of Life and Sense of Stigmatization in Psoriatics.

Authors:  Beata Kowalewska; Barbara Jankowiak; Mateusz Cybulski; Elżbieta Krajewska-Kułak; Dzmitry Fiodaravich Khvorik
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-02-02

7.  The Sense of Stigmatization in Patients with Plaque Psoriasis.

Authors:  Barbara Jankowiak; Beata Kowalewska; Elżbieta Krajewska-Kułak; Krystyna Kowalczuk; Dzmitry F Khvorik
Journal:  Dermatology       Date:  2020-08-25       Impact factor: 5.366

8.  Acceptance of Illness, Satisfaction with Life, Sense of Stigmatization, and Quality of Life among People with Psoriasis: A Cross-Sectional Study.

Authors:  Beata Kowalewska; Mateusz Cybulski; Barbara Jankowiak; Elżbieta Krajewska-Kułak
Journal:  Dermatol Ther (Heidelb)       Date:  2020-03-19

9.  Stigmatization and Quality of Life in Patients with Psoriasis.

Authors:  Barbara Jankowiak; Beata Kowalewska; Elżbieta Krajewska-Kułak; Dzmitry F Khvorik
Journal:  Dermatol Ther (Heidelb)       Date:  2020-03-07

10.  Efficacy of psychological intervention for patients with psoriasis vulgaris: a prospective study.

Authors:  Xiaoli Li; Liangliang Liu; Yanfei Zhang; Li Li
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.